# Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria

> **NCT01230034** · PHASE3 · UNKNOWN · sponsor: **University of Pavia** · enrollment: 206 (estimated)

## Conditions studied

- Hypertension
- Type 2 Diabetes Mellitus
- Microalbuminuria

## Interventions

- **DRUG:** Ramipril
- **DRUG:** Imidapril

## Key facts

- **NCT ID:** NCT01230034
- **Lead sponsor:** University of Pavia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2011-06
- **Final completion:** 2011-07
- **Target enrollment:** 206 (ESTIMATED)
- **Last updated:** 2010-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01230034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01230034, "Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01230034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*